Mechanistically, the loss of PML increases STAT1 binding to the CXCL10 promoter, likely associated with a PML-regulated region on the promoter, thus upregulating CXCL10 expression in tumor cells and aiding the infiltration of immune cells (84). The gene discussed is PML; the disease is neoplasm.